Results 151 to 160 of about 48,453 (241)

Development of Nipah virus mRNA vaccine for pandemic preparedness. [PDF]

Front Immunol
Kim JI, Fatima M, Seo EH, Park PG, Hong KJ.   +4 more
europepmc   +1 more source

ISEV2026 Abstract Book

Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

E3 ligase UHRF2 hijacks nuclear TBK1 to epigenetically repress type I interferons expression. [PDF]

Int J Biol Sci
Huang W, Song R, Shen Q, Shi Y, Wang X, Li N, Zhang Q, Cao X.   +7 more
europepmc   +1 more source

Molecular cloning and antiviral function analysis of pigeon interferon lambda(piIFN-λ). [PDF]

Poult Sci
Huang Q, Yang F, Wu S, Jiao P.
europepmc   +1 more source

BaEV-pseudotyped lentiviral vectors enable stable CAR expression and cytotoxic function in NK cells. [PDF]

PLoS One
Park M, Lim Y, Jo Y, Jo DH, Kim SK, Kim HY, Lee SH, Lee M, Cho D.   +8 more
europepmc   +1 more source

Endothelial injury is a central driver of systemic IFN-β toxicity and is reversible through Jak inhibition. [PDF]

Mol Ther Oncol
Zhang L, Pham L, Steele MB, Jenks N, Nace R, Russell SJ, Peng KW.   +6 more
europepmc   +1 more source

Low-density lipoproteins in human serum competitively inhibit the binding and entry of vesicular stomatitis virus. [PDF]

Mol Ther Adv
Vandergaast R, Johnson S, Ziegler C, Nenavath GN, Schnebeck L, Narjari R, Russell SJ.   +6 more
europepmc   +1 more source

Confirming ERVEBO Vaccination to Support Ebola Virus Surveillance. [PDF]

Emerg Infect Dis
Karaaslan E, Whitesell A, Malenfant J, Carson WC, Townsend M, Jolie KK, Koivogui E, Grovogui SM, Diallo B, Gbamou N, Corvil S, Boumbaly S, Martel L, Sinclair JR, Camara A, Shoemaker T, Choi MJ, Montgomery JM, Spiropoulou CF, Bergeron É.   +19 more
europepmc   +1 more source

Protein Priming Followed by a Replication-Competent VSV-GP Vector Boost Induces Sustained Immune Control in Therapeutic Hepatitis B Vaccination. [PDF]

Vaccines (Basel)
Su J, Kosinska AD, Miko S, Ates Öz E, Laer DV, Kimpel J, Protzer U.   +6 more
europepmc   +1 more source

Engineering precision oncology: Targeting tumors and immune cells with lentiviral vectors. [PDF]

Mol Ther Oncol
Rossi J, Martinello C, Sorrentino R, Guyonnet-Duperat V, Amintas S, Abrey Recalde MJ, Verhoeyen E, Dabernat S.   +7 more
europepmc   +1 more source